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Despite the promises of data-driven articial intelligence (AI), lile is known about how we can bridge the
gulf between traditional physician-driven diagnosis and a plausible future of medicine automated by AI.
Specically, how can we involve AI usefully in physicians’ diagnosis workow given that most AI is still
nascent and error-prone (e.g., in digital pathology)? To explore this question, we rst propose a series of
collaborative techniques to engage human pathologists with AI given AI’s capabilities and limitations, based on
which we prototype Impetus—a tool where an AI takes various degrees of initiatives to provide various forms
of assistance to a pathologist in detecting tumors from histological slides. Finally, we summarize observations
and lessons learned from a study with eight pathologists and discuss recommendations for future work on
human-centered medical AI systems.
CCS Concepts: •Human-centered computing → Empirical studies in interaction design; •Applied
computing→ Life and medical sciences; •Computing methodologies→ Machine learning;
Additional Key Words and Phrases: Digital pathology; Medical AI; Human-AI collaboration; Human-centered
AI;
ACM Reference format:
Hongyan Gu, Jingbin Huang, Lauren Hung, and Xiang ‘Anthony’ Chen. 2020. Lessons Learned from Designing
an AI-Enabled Diagnosis Tool for Pathologists. J. ACM 1, 1, Article 1 (January 2020), 23 pages.
DOI: xx.xxxx/xxxxxxx.xxxxxxx
1 INTRODUCTION
e recent development of data-driven articial intelligence (AI) is rejuvenating the use of AI in
medicine that originally started over half a century ago. Enabled by data-driven statistical models,
AI can already read X-Ray images [8, 24] and analyze histological slides [7, 35] with a performance
on par with human experts.
Despite their promises of automating diagnosis, existing medical AI models tend to be ‘imperfect’
[6]—there remain inherent limitations in the models’ performance and generalizability. For example,
in digital pathology, scanned tissue slides are processed by AI to detect tumor cells. e problem is
that such histological data (e.g., ovarian carcinoma) tends to have a high between-patient variance
[27]; thus, a pre-trained model oen struggles to generalize when deployed to a new set of patients.
At present, it remains underexplored how to integrate such ‘imperfect’ AI usefully into physicians’
existing workow.
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Researchers have long realized the limitation of using AI as a ‘Greek Oracle’. Miller and Masarie
pointed out that a “mixed initiative system” is mandatory whereby “physician-user and the con-
sultant program should interact symbiotically” [34]. Some research focused on mimicking how
doctors think [14, 42], such as using an aention-guided approach to extract local regions of
interest on a thoracic X-ray image [17]; others developed explainable models [10, 53] or system
designs [46, 47] that promote a doctor’s awareness of AI’s diagnosis process. Cai et al. developed
a content-based image retrieval (CBIR) tool that allows a pathologist to search for similar cases
by region, example or concept [6]. Yang et al. conducted eld work to identify when and how AI
can t in the decision-making process of vascular assist device transplant [50, 51]. Despite such a
growing body of work on mental models, explainability, CBIR tools and eld study, lile is yet able
to answer the following question for medical AI: when AI is still nascent and error-prone, how can
physicians still make use of such ‘imperfect’ AI in their existing workow of diagnosis?
To ground the exploration of this question, we focus on medical imaging—the primary data
sources in medicine [26]. Amongst various medical imaging techniques, histological data in
digital pathology [19], in particular, presents some of the most dicult challenges for achieving
AI-automated diagnosis, thus serving as an ideal arena to explore the interactional relationship
between physicians and AI.
Focusing on digital pathology as a point of departure, we propose a series of physician-AI collab-
oration techniques, based on which we prototype Impetus—a tool where an AI aids a pathologist in
histological slide tumor detection using multiple degrees of initiatives. Trained on a limited-sized
dataset, our AI model cannot fully automate the examination process; instead, Impetus harnesses
AI to (i) guide pathologists’ aention to regions of major outliers, thus helping them prioritize the
manual examination process; (ii) use agile labeling to train and adapt itself on-the-y by learning
from pathologists; and (iii) take initiatives appropriately for the level of performance condence,
from automation, to pre-lling diagnosis, and to defaulting back to manual examination. We used
the Impetus prototype as a medium to engage pathologists and observe how they perform diagnosis
with AI involved in the process and elicit pathologists’ qualitative reactions and feedback on the
aforementioned collaborative techniques. From work sessions with eight pathologists from a local
medical center we summarize lessons learned as follows.
Lesson #1 To explain AI’s guidance, suggestions and recommendations, the system should go
beyond a one-size-ts-all concept and provide instance-specic details that allow a medical user to
see evidence that leads to a recommendation.
Lesson #2 Medical diagnosis is seldom a one-shot task, thus AI’s recommendations need to
continuously direct a medical user to lter and prioritize a large task space, taking into account
new information extracted from a user’s up-to-date input.
Lesson #3 Medical tasks are oen time-critical, thus the benets of AI’s guidance, sugges-
tions and recommendations need to be weighed by the amount of extra eorts incurred and the
actionability of the provided information.
Lesson #4 To guide the examination process with prioritization, AI should help a medical user
narrow in small regions of a large task space, as well as helping them lter out information within
specic regions.
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Lesson #5 It is possible for medical users to provide labels during their workow with acceptable
extra eort. However, the system should provide explicit feedback on how the model improves as a
result, as a way to motivate and guide medical users’ future inputs.
Lesson #6 Tasks treated equally by an AI might carry dierent weights to a medical user. us
for medically high-staked tasks, AI should provide information to validate its condence level.
Importantly, these lessons reveal what was unexpected as pathologists collaborated with AI
using Impetus’ techniques, which we further discuss as design recommendations for the future
development of human-centered AI for medical imaging.
1.1 Contributions
Our contributions are as follows.
• e rst suite of interaction techniques in medical diagnosis that instantiate mixed-initiative
principles [20] for physicians to interact with AI with adaptive degree of initiatives based on
AI’s capabilities and limitations;
• A proof-of-concept system that embodies these techniques as an integrated diagnosis tool for
pathologists to detect tumors from histological slides;
• A summary of observations and lessons learned from a study with eight pathologists that
provides empirical evidence of employing mixed-initiative interaction in the medical imaging
domain, thus informing future work on the design and development of human-centered AI
systems.
2 RELATEDWORK
Our review of literature starts from a general body of cross-disciplinary work on human-AI
interaction, gradually drill down to the (medical) imaging domain, and nally summarize current
status on digital pathology, which exemplies the gap between traditional manual diagnosis and
not-yet-available AI-enabled automation.
2.1 Human-AI Interaction
Since J. C. R. Licklider’s vision of ‘man-machine symbiosis’ [28], bringing human and AI to collabo-
ratively work together has been a long-standing challenge across multiple elds.
In particular, machine learning and data science could leverage human involvement to overcome
problems challenging for existing computational methods or systems. Fort enables designers
to interactively express and rene sketch-based 2D design automated by topology optimization:
specically, a user can modify optimization’s result, which serves as input for the next iteration to
reect the user’s intent [12].
Amershi et al. propose a system that gives the user exibility to provide beer training examples
in interactive concept learning [1]. e system also allows users to control the learning process
and helps them decide when to stop training to avoid overing problems. Chau et al. combine
visualization, user interaction, and machine learning to guide users to explore correlations and
to understand the structure of large-scale network data [11]. Suh et al. show that classier
training with mixed-initiative teaching is advantageous over both computer-initiated and human-
initiated counterparts. Specically, mixed-initiative training could signicantly reduce the labeling
complexity across a broad spectrum of scenarios, from perfect, helpful teachers who always provide
the most helpful teaching, to naive teachers who give the completely unhelpful labels [45]. Felix
et al. propose a topic modeling system that could nd unknown labels for a group of documents:
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by integrating human-driven label renement and machine-driven label recommendations, the
system enables analysts to explore, discover and formulate labels [16].
Research also has shown that human-AI interaction can enhance domain-specic tasks. For
example, Nguyen et al. combine human knowledge, automated information retrieval and ML,
enabling a mixed-initiative approach to fact-checking [36].
To democratize the design of human-AI interaction, Horvitz articulated a series of principles of
mixed-initiative interaction via an example of an email-to-calendar scheduling agent [20]. Insights
from Horvitz’s work was renewed in a recent paper by Amershi et al., which proposes and validates
18 guidelines for human-AI interaction, which includes, for instance, “support ecient correction”,
“make clear why the system did and what it did”, “convey the consequences of user actions” [2].
Below we delve into the digital imaging process domain to review prior work where human-AI
interaction can contribute.
2.2 Data-Driven Digital Image Processing
Imaging provides an abundant source of clinical data in medicine [26]. While data-driven AI
has served as a powerful toolkit for processing digital images, human involvement remains an
indispensable part, primarily manifested in the provision of training labels.
Ilastik [44] enables users to draw strokes over images for training segmentation models. e
system can automatically recommend the most important features to reduce overing. However,
the microscopic nature of such labels demands a lot of users’ eort to achieve whole-slide level
performance. HistomicsML is an active learning [41] system that dynamically queries the most
uncertain patches from a random forest classier, thus allowing pathologists to rene the clas-
sication model with fewer samples iteratively. Instead of selecting the most uncertain samples,
Zhu et al. also consider the samples that would contribute most to ‘shrinking’ the hypothesis
space. e paper also takes the structural hierarchy of digital histological images into account: the
queried samples are spanned across dierent tissue partitions by the most diverse manner [55]. As
indispensable as it is, human input is oen unavailable due to the accumulated eort of labeling a
large amount of data.
To lower the requirement of human eort, one approach is to rely on existing whole slide-level
labels, thus dispensing with the need for users to label at the pixel-level. Xu et al. employ a
multiple instance learning (MIL) approach [49] to train a patch-level classier based on slide-level
annotations. However, it oen requires a large amount of slide-level annotation for training;
otherwise, there is oen a performance drop compared to using strongly-supervised labels on the
same set of slides. Ilse et al. use an aention-based deep multiple instance learning method to
learn a Convolutional Neural Network (CNN) with image-level annotations. e learned CNN can
highlight areas that contribute the most to image-level classication results. is approach can
be applied to breast or colon cancer detection, with reported performance higher than other MIL
approaches without sacricing interpretability [21]. Campanell et al. combine MIL and Recurrent
Neural Network models on slide-level diagnosis with prostate cancer, basal cell carcinoma, and
breast cancer metastases. e model was trained on more than 44,000 slides from more than 15,000
patients and achieved an AUC score of ¿ 0.96 in all three types of diseases.
2.3 Interactive Tools for Digital Pathology
Digital pathology, similar to biology research, oen deals with high-resolution, visually challenging
images. Beyond involving AI trained by domain experts, tools that allow pathologists to dene,
explore, and decide upon clinical or research problems are also needed.
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ImageJ [40] is one of the scientic image analysis tools that have been popularly used or extended
by computational medicine research. e platform provides basic image processing tools, such as
image enhancement and color processing, and allows users to perform various image operations,
such as cropping, scaling, measuring, and editing. Based on ImageJ, various distributions [13, 37, 39]
and plugins [25] have been increasingly integrated into the system, making it the most widely used
soware in digital pathology [25].
A variant of tools are designed primarily for research for digital pathology. For example, Cell-
proller [9] is a cell analysis tool that assists non-computational users to quantitatively perform
standard assays as well as complex morphological assays automatically without writing any code.
caMicroscope [38] enables a user to run a segmentation pipeline in a selected area and to quanti-
tatively analyze nuclei characteristics (e.g., shape, size, intensity, texture features) in whole-slide
images (WSIs). Path [4] provides extensive annotation and visualization tools for pathologists
to brush over the lesion tissues rapidly. It also provides a set of ready-to-use analysis algorithms
to construct customized workow for powerful batch processing, with additional exibility for
developers to add extensions and applications. Pathology Image Informatics Platform (PIIP) [33]
extends the capabilities of Sedeen viewer1 by adding plugins on out-of-focus detection, region of
interest transformation, and immunohistochemical (IHC) slide analysis.
Recent research [47, 48, 50, 51] suggests that, besides reasoning with medical data, the design of
a diagnosis tool oen needs to take into consideration physicians’ established workow and other
domain-specic behaviors. Some digital pathology tools further address the collaborative nature
of performing large-scale, image-based studies. Cytomine [32], for example, provides web-based
support for organizing, exploring and analyzing multi-gigapixel level image data among team
members. Others focus on data curation and management, e.g., Digital Slide Archive [18], which
enables users to build their own web digital pathology archives by integrating massive image
databases with clinical annotations and genomic metadata.
3 IMPETUS: AN AI-ENABLED TOOL FOR PATHOLOGISTS
Before we unfold our design process in the next section, we rst introduce the background of
digital pathology and the motivation to involve AI. We then walk through Impetus’s scenario to
present a high-level overview of how the tool works with pathologists.
3.1 Background of Digital Pathology
Central to digital pathology are whole-slide images or WSI for short. WSIs are produced by high-
speed slide scanners that digitalize the glass slide at very high resolution, resulting in gigapixel
images [29]. Due to its large and high visual variance, a WSI cannot be directly fed into a model
such as a Convolutional Neural Network (CNN) classication. A WSI is usually divided into small
patches, which are then classied by a CNN model. ese patch level predictions can then be
assembled to create a tumor probability heatmap, from which a pathologist can derive a whole-slide
level diagnosis.
In our study, we used a dataset containing H&E stained sentinel lymph node (SLN) sections of
breast cancer patients [29]. e diagnosis of such specimens contains four main categories [3]:
• Isolated tumor cells (ITC) if the node contains single tumor cell or cell deposits that are
no larger than 0.2 mm or contain fewer than 200 cells;
• Micro if containing metastasis greater than 0.2 mm and/or more than 200 cells;
• Macro if containing metastasis greater than 2 mm;
• Negative if containing no tumor cells.
1hps://pathcore.com/sedeen/
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3.2 Promises & Challenges of AI for Digital Pathology
Digital pathology transforms traditional microscopic analysis of histological slides into high-
resolution digital visualization [19]. Digital pathology allows pathologists to investigate ne-
grained pathological information, transfer previously-learned knowledge to new tasks [19], and,
most importantly, to leverage the recent development of data-driven AI to augment their visual
analytical tasks.
However, the main challenge for digital pathology is that, unlike other imaging modalities (e.g.,
X-Ray, CT), histological data (e.g., ovarian carcinoma) tends to have a high between-patient variance
[27]; thus a pre-trained model oen struggles to generalize when deployed to a new set of patients.
Such an uncertainty of performance creates a barrier that prevents AI from being adopted to assist
diagnosis in digital pathology.
To overcome this barrier, one solution is to improve the machine learning model by training it
on a suciently large amount of patient data using cost-eective labeling and learning schemes
[7, 35]. However, such a ‘big data’ approach aempts to close the gap by (marginally) improving
AI’s performance, while ignoring the opportunity to engage human physicians. As a result, eorts
are oen bound to repeat the ‘Greek Oracle’ pitfall pointed out by Miller and Masarie almost three
decades ago [34]. e focus of our paper is to explore and study the o-missed opportunity of
combining physicians with an ‘imperfect’ AI: rather than awaiting AI to be fully automatable one
day, how can we make use of its capability with limitations today?
Below we describe a scenario walkthrough of Impetus—a tool that explores how AI—without yet
the ability to diagnose fully-automated —can still empower pathologists by becoming an integral
part of their workow.
3.3 Scenario Walkthrough
e user of Impetus, a pathologist, starts the diagnosis of a patent’s case by importing multiple
Whole Slide Images (WSI) of the patient into Impetus.
First, the pathologist’s aention is drawn to the two boxes generated by the AI, which encompass
regions of patches that visually appear to be ‘outliers’ from the majority of cells (Figure 1(a)), which
suggests that these patches are likely to be tumor-positive. With these automatic recommendations,
Impetus alleviates the pathologist’s burden of navigating a large, high-resolution image and having
to go through a large number of areas that might or might not be as tumor-characteristic as the
recommended regions.
Next, the pathologist performs diagnosis by marking each recommended region as either ‘tumor’
or ‘normal’, and continues to marquee-select and label a few more regions on the WSI (Figure 1(b)).
As the pathologist makes such diagnoses, their input is also collected by the back end AI and used
as labels to adapt the model beer to align itself with the pathologist’s domain knowledge. In
contrast to conventional data labeling tasks, Impetus’ agile labeling is designed to be lightweight
and able to learn from pathologists’ input of coarsely marked regions without having to trace a
precise contour of a tumor region. In this way, Impetus allows pathologists to agilely train an AI
model as a natural and integral part of their existing workow without incurring extra eort.
As the pathologist diagnoses more WSIs (which also trains the AI), they notices that some new
slides are already marked as ‘diagnosed’—AI takes the initiative to diagnose slides that it feels
highly condent about. us the pathologist skips ahead to see other unlabeled slides, some of
which, have pre-lled diagnosis dialogues (Figure 1(c)). In such cases, the pathologist examines the
WSI to verify the AI’s hypothesis. In the rest of the WSIs, the AI almost becomes invisible (due to a
lack of condence) and the pathologist proceeds to manually nish the diagnostic tasks.
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Fig. 1. Key interactive features of Impetus: (a) as a pathologist loads a whole slide image, AI highlights
areas of interest identified by outlier detection, shown as two yellow recommended boxes. (b) Agile labeling:
pathologist can drag and click to provide a label that can be used to train the AI’s model. (c) Diagnosis
dialogue, pre-filled with AI’s diagnosis, allows the pathologist to either confirm or disregard and proceed
with manual diagnosis.
e above scenario demonstrates how an ‘imperfect’ AI can still benet a pathologist without
necessarily automating the user’s existing workow: recommendation boxes suggestively prioritize
pathologists’ manual searching process (Figure 1(a)), agile labeling adapts AI while minimizing
the extra eort from the pathologists (Figure 1(b)), and as AI aempts to improve itself, it handles
cases with dierent degrees of initiatives—from fully automation to pre-lling plausible results to
remaining complete ‘invisible’—based on its condence (Figure 1(c)).
4 DESIGN AND IMPLEMENTATION
Below we rst describe the design process then detail the specic interaction techniques and their
implementation in Impetus.
4.1 Overview of the Design Process: Empirical & Theoretical Grounding
e design of Impetus is grounded in both empirical evidence and principles drawn from literature.
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Fig. 2. A physician’s dierential diagnosis process is similar to a funnel, starting with a broad exploration
of plausible conditions and gradually rule out less likely possibilities as more evidence (e.g., test results) is
gathered until finally a single most probable conclusion can be drawn. Impetus supports exploration near
Point A by enabling pathologists’ initial exploration with recommended regions. Image credit: Blois [5].
On the empirical side, we co-designed Impetus with our pathologist collaborator. Specically,
we learned that one major challenge for pathologists is the ability to eciently and eectively
navigate large, high-resolution WSIs. is suggests that AI, besides making diagnosis, can usefully
serve to guide pathologists to navigate complex and high-resolution image space. We detail this
design in §4.2.
On the theoretical side, Impetus goes beyond the singular objective of automation by oering a
spectrum of AI-enabled assistance. As pointed out by Blois’ seminal paper, a physician’s dierential
diagnosis process is similar to a funnel, starting with a broad exploration of plausible conditions
and gradually rule out less likely possibilities as more evidence (e.g., test results) is gathered until
nally a single most probable conclusion can be drawn. According to Blois, AI has been canonically
developed to optimize Point B where a computer program can deterministically conrm whether
a patient has a certain disease given all the evidence. As Blois foresaw, a recent development of
AI starts to exhibit capabilities towards Point A, e.g., Stanford’s CheXpert produces likelihoods of
10+ thoracic diseases based on a chest X-ray image [23]. Similarly, Impetus also aims at “reaching
Point A” by enabling pathologists’ initial exploration with recommended regions.
Overall, Impetus provides the rst suite of interaction techniques in the medical imaging domain
that instantiate mixed-initiative principles [20] for physicians to interact with AI with adaptive
degree of initiatives based on AI’s capabilities and limitations. Specically, we focus on the following
principles in [20]:
• Scoping precision of service to match uncertainty. We rst design a rule-based algorithm to
identify three levels of uncertainty in AI’s performance given a WSI (detailed in §4.4), based
on which we then design the corresponding AI-initiated action appropriate for each level of
uncertainty (Table 1).
• Providing mechanisms for ecient agent-user collaboration to rene results. For each AI-initiated
action, we also design mechanisms to introduce physician-initiated actions aimed at conrm-
ing, rening or even overriding AI’s results (Table 1). Further, we extend this principle by
leveraging physician-initiated input for ‘machine teaching’ [43], i.e., an agile labeling technique
to dynamically adapt an AI by retraining it with examples of how a physician interpret a
patient’s histological data (detailed in §4.3).
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4.2 AI Guiding Pathologists’ Aention to Regions of Major Outliers
In our communication with our pathologist collaborator, we learned that one major limitation of
pathologists is the ability to eciently and eectively navigate a large, high-resolution WSI. To
address this limitation, we design AI to guide pathologists’ aention to regions of major outliers
that appear visually dierent from the rest of the WSI and are more likely to be tumors. Such
guidance is manifested in two user interface elements:
(i)Attentionmap visualizes each patch’s degree of outlying overlaid on the current WSI (Figure
3(a)); (ii) Recommendation boxes as a more explicit means to draw pathologists’ aention to
large clusters based on outlier detection results (Figure 1(a))—these boxes are always visible, whether
on the original WSI, on the aention, or on the prediction map (described below).
Implementation When the system is rst loaded, a model trained with PatchCamelyon dataset2
extracts patch features in WSIs. In the rst iteration, the system performs outlier detection based on
extracted features, and the detected outliers are highlighted in the aention map. In the following
iterations, the aention map is a combination of outliers (from the initial detection) and high
uncertainty patches (from specic models in each iteration). In order to obtain the recommendation
boxes, the system clusters WSI patches with aention value. In each iteration, the recommendation
boxes are selected as the two clusters which occupies the largest areas on the WSI.
Fig. 3. The two maps used by Impetus to provide guidance and communicate AI results. (a) Aention map,
where outlier patches and high uncertainty patches are highlighted in red, while other patches are in blue.
Yellow recommendation boxes are generated by clustering aention values. (b) Prediction map, where red
shows high probability of tumor, and white shows a low probability of tumor, as predicted by the AI. The
green and red boxes are areas of ”normal” and ”tumor”, as labeled by the pathologist. Recommendation boxes
generated by clustering aention values are also visible on this map.
2hps://patchcamelyon.grand-challenge.org/
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4.3 AI Using Agile Labeling to Train and Adapt Itself On-the-fly
In digital pathology, the main challenge for AI is that, unlike other imaging modalities (e.g., X-
ray, CT), histological data (e.g., ovarian carcinoma) tends to have a high variance across slides of
dierent patients (sometimes same patients as well) [27]. us a pre-trained model oen struggles
to generalize to new data. To address this limitation, we design Impetus, where pathologists
use agile labeling to train AI on the y. Agile labeling allows a pathologist to directly label
on recommendation boxes (Figure 1(a)) or to draw a bounding box of tumor-negative patches
(Figure 1(b)), or a box containing a mix of negative and positive cells, which serve as labels to
train an existing model further to incorporate pathologists’ domain knowledge. Importantly, such
labeling technique is designed to be agilely achievable without incurring signicant extra eort
that interrupts the main diagnosis workow.
Implementation Agile labeling does not specically require users to provide the exact contour
of tumor tissues in a WSI, as strongly-supervised learning does. Alternatively, a user can marquee-
select a positive box over an area which contains at least one tumor patches, or a negative box on
all negative regions. We implemented a weakly-supervised multiple instance learning (MIL) [54] to
enable a traditional random forest algorithm to learn over such agile labels. To train the model, the
system rst initializes a positive set and neдative set . In the MIL setup, each Xi is a feature set
within a box and only has one box-level label Yi . For a negative box, all the instances in the box
can be included in neдative set . For positive boxes, the system uses T-SNE [31] to represent the
high-dimension features Xi with two-dimension embedding X i . en, a K-Means clustering is used




i . Aer clustering, the algorithm compares the two clusters
with negative samples from negative box Xneд to pick the real positive cluster. Aer the positive
cluster is recognized, all the instances in the positive cluster are included in the positive set . Finally,
a random forest classier (MIl-RF) is trained with the obtained positive set and neдative set , and
the user can continuously provide more annotations until the trained classier reaches a satisfactory
level of performance.
4.4 AI Taking Initiatives Appropriately for the Level of Performance Confidence
Even with agile labeling, lightweight on-the-y learning only has limited improvement compared
to training extensively oine. us it is crucial to convey the level of AI’s performance to the
pathologists. In Impetus, AI takes initiatives appropriately for its performance condence level, as
manifested in the following two user interface elements: (i) Prediction map visualizes current
AI’s results overlaying the WSI, which serves to inform both the labeling and the usage of the
current AI’s model (Figure 3(b)). (ii) Initiatives based on condence—the more uncertain the AI
‘feels’ about a WSI, the less initiative it takes, as shown in Table 1.
Implementation Impetus has a rule-based condence-level classier to sort slides into three
categories: high-condence, mid-condence, and low-condence. First, predictions of all the
patches in the WSI are obtained. A patch has two characteristics: is positive and is uncertain. A
patch is positive if the MIL-RF classier output ¿ 0.5, and is uncertain if MIL-RF classier output
∈ [0.25, 0.75]. We empirically summarize the condence-level decision rules3 as follows:
• If there are more than 200 positive patches AND the number of positive patches is greater than
twice the number of uncertain patches, then the slide is predicted as high-condence;
• If there are no outlier clusters, then the slide is predicted as low-condence;
• If the number of uncertain patches is greater than 300, then the slide is predicted as low-
condence;
3… which can be easily modied as a conguration le of our tool.
Journal of the ACM, Vol. 1, No. 1, Article 1. Publication date: January 2020.
Lessons Learned from Designing an AI-Enabled Diagnosis Tool for Pathologists 1:11
Table 1. Spectrum of human and AI initiatives at dierent AI confidence levels.
AI Condence AI-Initiated Action Physician-Initiated Action
High Performing diagnosis automatically in the
background; marking WSIs as diagnosed
Doing nothing and accepts AI’s results;
can re-open a WSI to overwrite AI’s result
↑ Pre-lling the diagnosis box without di-
rectly labeling the WSI
Performing diagnosis with help from AI
predictions; conrming or correcting the
pre-lled dialogue
Low Showing original WSI by default to
prompt for manual diagnosis
Performing diagnosis with lile input
from AI
• If the number of positive patches is greater than 200, then the slide is predicted as high-
condence;
• For all other cases, the slide is predicted as mid-condence.
5 WORK SESSIONS WITH PATHOLOGISTS
To validate our design of Impetus, we observed how pathologists used this tool to perform diagnosis
on a clinical dataset [29]. Our goal is to study whether the AI in Impetus (i) can be compatibly
integrated into pathologists’ workow and (ii) can provide added values to pathologists’ diagnosis
process.
Participants We recruited eight medical professionals from the pathology department in a local
medical center. e participants have experiences ranging from 1 to 43 years, including residents,
fellows, and aending pathologists.
Data & apparatus We used the Camelyon 17 [29] dataset and selected 16 WSIs4 that were
collected in the same medical center. Participants interacted with Impetus on a 15-inch laptop
computer using a wired mouse. Impetus ran on a Microso Windows 10 Operating System using
an Nvidia 960M GPU and 16GB RAM.
Design Our discussion with pathologists collaborators and an initial screening survey indicated
that currently there was not a single commonly used tool for digital pathology. To help pathologists
calibrate their experience with Impetus, we introduced another tool—ASAP5, which represents
a very basic manual tool for viewing and annotating digital pathology slides. Each pathologist
interacted with both Impetus and ASAP, which were referred to as System A and System B,
respectively, to avoid biasing the pathologists. e order of tools was counterbalanced across the
eight pathologists. Twelve of the 16 slides were diagnosed using Impetus and the remaining four
using ASAP: we chose to keep more slides for Impetus as it was the target of our study, whereas
ASAP was just to calibrate pathologists’ tool experience.
Tasks & Procedure Aer briey introducing the background of computer-assisted diagnosis, we
walked each pathologist through a tool and let them practice on a separate toy dataset also gathered
from [29]. We then asked questions about how the participant understood dierent interactive
components, whether the tool was easy to learn and use, and whether the tool was helpful to their
diagnosis. en, the primary task began, which was to diagnose the entire group of WSIs using
4Our pilot studies indicated that 16 is the number of WSIs that would allow us to nish the session in about an hour to most
eectively use the pathologists’ time.
5hps://computationalpathologygroup.github.io/ASAP/
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Fig. 4. We conducted work sessions with eight pathologists from a local medical center to observe how they
used Impetus as part of their diagnosis process.
the provided tool in each condition. A trial started with a participant clicking to open a WSI and
nished when they selected a diagnosis and clicked the ‘Conrm’ buon. Aer each condition,
we further conducted a brief semi-structured interview for each participant to summarize their
experience, feedback, and suggestions for the tool. Participants took a short break between the two
conditions.
Analysis We employed an iterative open-coding method to analyze the qualitative data collected
from the semi-structured interviews with pathologists. Two experimenters coded each participants
data within one day aer the study. One experimenter performed the rst pass of coding and updated
a shared codebook, which was then reviewed by the other experimenter to resolve disagreements.
e two experimenters alternated the roles of the rst coder and reviewer. Aer all the participants
data were coded and consolidated, a third experimenter reviewed all the codes and transcripts
and resolved disagreements through discussion with the previous two experimenters. Finally, we
arrived at six high-level themes, which we summarize below as lessons learned.
6 FINDINGS & LESSONS LEARNED
Based on the observations and data from the work sessions with pathologists, we present our
ndings below, which are summarized into six lessons. To maintain consistency, we organize these
lessons using the same structure as §5.
6.1 AI Guiding Pathologists’ Aention to Regions of Major Outliers
6.1.1 Recommendation boxes. (Figure 1a) were the most frequently used and discussed features
during the study. We observed that in almost all the trials pathologists started by zooming into the
recommendation boxes and tried to provide annotations of the outlined region. Pathologists found
it helpful to have such concrete start points in their examination.
… [recommendation boxes] narrow down the area of interest … it helps (P7)
It was less eort because I was focusing only on the aention areas and not focusing
on the other areas of the node so it was dierent from my usual way of looking at a
slide. (P2)
However, pathologists did not always nd the recommended regions matched their intuition
and they could not understand why certain regions were recommended.
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… [the recommendation box] seems a lile bit random. It’s not necessarily areas that
I would [look at] … (P5)
e things it’s focusing on does not correlate with at least what my brain thinks I am
looking for. (P6)
A lack of transparency is not a new problem in recommender system research (e.g., [52]). When
introducing Impetus, we did explain that recommendation boxes were based on a detection of
visual outliers and all pathologists acknowledged that they understood such a concept. Although
such outliers were computed based on histological features (the PatchCamelyon dataset), they
did not always agree with what pathologists intuited as ‘interesting’ regions worth examination.
When such a mismatch occurred—i.e., an unexpected case of recommendation, pathologists could
no longer reason about the recommendation boxes simply by referring to the abstract concept of
‘visual outliers’. At times, pathologists started to develop their own hypothesis of how AI was
processing the WSI: “… it’s interesting that it’s picking area with fat as area of interest.” (P2)
Lesson #1 To explain AI’s guidance, suggestions and recommendations, the system should go
beyond a one-size-ts-all concept and provide instance-specic details that allow a medical user to
see evidence that leads to a recommendation.
We also found that pathologists wondered what they should do about the area outside of the
recommendation boxes:
So I just look at the ones in the [recommendation] square? (P7)
Am I supposed to assume the rest of it is normal? I don’t have to go searching for the
rest of the slides for [tumor]? (P2)
Pathologists understood the implication in the recommendation boxes, i.e., to prioritize certain
regions of a WSI and to serve as a ‘shortcut’ in lieu of scanning the entire WSI. However, it was
unclear what was the implication outside of the recommendation boxes. is is especially true
when pathologists could not nd signs of tumor in the recommended regions: the system did not
continue to guide them on how to proceed with the rest of the WSI.
Lesson #2 Medical diagnosis is seldom a one-shot task, thus AI’s recommendations need to
continuously direct a medical user to lter and prioritize a large task space, taking into account
new information extracted from a user’s up-to-date input.
6.1.2 Aention map. (Figure 3a) visualizes outliers detected by the AI—the same information
based on which the recommendation boxes were drawn. It was designed to complement recommen-
dation boxes with a backdrop of detailed guidance. We expected pathologists to use the aention
map similarly as the recommendation boxes, i.e., to direct their aention to look for more outlying
regions for examination. However, pathologists did not nd aention map useful:
e aention map shows the same thing as the recommended box. e box is enough
to direct my aention. (P2)
I don’t really see the point of the aention map … ese two maps are redundant. (P4)
e main dierence was that recommendation boxes cost less eort to process, while aention
map needed to be navigated (i.e., panned and zoomed and interpreted (i.e., mentally ‘decoding’ the
color scheme). Further, recommendation boxes provided actionable information (i.e., to look into
this box rst), while aention map is action-neutral. Given that pathologists’ overall goal is to
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eliminate the amount of area to study, they tended to prefer less extra eort and information with
clearer actionability.
Lesson #3 Medical tasks are oen time-critical, thus the benets of AI’s guidance, sugges-
tions and recommendations need to be weighed by the amount of extra eorts incurred and the
actionability of the provided information.
6.2 AI Using Agile Labeling to Train and Adapt Itself On-the-Fly
Prediction map (Figure 3b) visualizes current AI’s diagnosis of the WSI and was designed to help
the pathologists assess the model’s performance and decide where they could provide more labels.
However, pathologists used prediction map dierently than we expected. Pathologists would
oen zoom into recommendation boxes on the WSI, study the region for a few seconds, then switch
to the prediction map for a few seconds, and switch back to WSI. ey tended to use the prediction
map as a tool to help them see if there is something ‘interesting’ in the current zoomed-in region.
Sometimes pathologists used the prediction map to double check their developing diagnosis:
at was all negative, and I didn’t get a strong heatmap signal, so it was conrmatory
and somewhat helpful. (P6)
Interestingly, how the prediction map was used by pathologists seemed to complement the
recommendation boxes: while recommendation boxes told pathologists which region is worth
looking at (i.e., might contain tumors), prediction map conrmed pathologists’ assumption when
they thought a region was of lile ‘interest’ (i.e., no signs of tumor).
Lesson #4 To guide the examination process with prioritization, AI should help a medical user
narrow in small regions of a large task space, as well as helping them lter out information within
regions.
e unexpected usage of prediction map aected agile labeling, as we discuss below.
Agile labeling (Figure 1b) allows a pathologist to directly label on a recommendation box, or to
marquee-select a region to coarsely annotate as normal or tumor. In the introduction phase, all
pathologists reported having no problem understanding the idea of continuously labeling WSIs to
improve the AI:
is is actually adding more work for me, but I would be willing to add labels knowing
I would be improving the model (P4)
However, during the tasks, we noticed that almost all the labels were drawn only based on the
recommendation boxes. Only one pathologist actively searched other regions to draw and provide
more labels. It seemed that recommendation boxes served as a prompt and pathologists were
unmotivated to label other regions if unprompted.
We believe one fundamental reason is a lack of feedback to inform pathologists how important
their labels were to the model retraining. Without such feedback, it might have been unclear to
pathologists whether they needed to provide labels at all, or how much labeling would be enough.
Do I need to add labels? (P6)
Should I have provided more labels? (P5)
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We assume that once pathologist see how a prediction map contained inaccurate results, they
would be motivated to provide more labels to improve the prediction. However, our observations
show that pathologists were more likely to make a diagnosis directly by manual examination,
instead of correcting AI’s predictions as we expected. Falling back to manual examination seems a
more cost-eective alternative to AI automation than trying to iteratively improve the AI.
Lesson #5 It is possible for medical users to provide labels during their workow with acceptable
extra eort. However, the system should provide explicit feedback on how the model improves as a
result, as a way to motivate and guide medical users’ future inputs.
6.3 AI Taking Initiatives Appropriately for the Level of Performance Confidence
As shown in Table 1, AI’s level of initiatives is mediated based on its level of condence about
the model’s performance. For low-condence cases, AI took no initiatives and all pathologists
were mostly unaware of AI’s presence, when they simply focused on performing the usual manual
diagnosis. For high-condence cases, as expected, pathologists quickly conrmed AI’s proactive
diagnosis of macro—the easiest type of tumor to detect by both pathologists and AI. However,
when it comes to cases diagnosed as negative by the AI, pathologists tended to perform a manual
diagnosis anyway:
On the ones that it said it’s condent but didn’t really tell you it’s negative, I still felt
like I had to look at those to conrm. I wasn’t going to trust the system [to conrm]
that it’s negative (P2)
In pathology, in order to rule out tumors, pathologists have to thoroughly examine the entire
WSI, whereas it only takes one positive case to diagnose the lymph node as positive. us there was
a discrepancy of trust between macro vs. negative, despite that AI treats both equally as dierent
labels of a slide image and categorizes both as high condence.
Lesson #6 Tasks treated equally by an AI might carry dierent weights to a medical user. us
for medically high-staked tasks, AI should provide information to validate its condence level.
For the mid-condence case, AI was designed to pre-ll the diagnosis dialog (but without any
conrmative action) as a way to hint its prediction without signaling any conclusive decision. is
design did not seem to have noticeable eects on the pathologists, which echos Lesson #3 that
information needs to present actionability in order to aect a medical user’s workow.
7 DESIGN RECOMMENDATION FOR HUMAN-CENTERED MEDICAL IMAGING AI
Extending the six lessons learned, we further discuss design recommendations for future develop-
ment in AI-enabled medical imaging. We describe each recommendation in the specic context of
Impetus as a way to ground the readers’ understanding, although we believe these recommenda-
tions can be extended to other AI-enabled medical imaging techniques (e.g., X-ray, CT, MRI), which
we leave as future work. Further, some of our recommendations suggest new technical challenges
for machine learning and AI communities.
Relationship to prior work. ere has been a school of prior work focusing on providing
guidelines for designing general human-AI interaction. Horvitz’s principles can be thought of
as a list of high-level requirements for a system to incorporate mixed-initiative interaction [20].
Amershi et al.’s list of guidelines informs how to design an AI’s behavior throughout interaction
[2]. Beyond these general guidelines, Yang et al. contribute insights on designing AI for the medical
domain based on eld studies. Wang et al. follow a top-down approach to develop a conceptual
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framework that links people’s reasoning processes to explainable AI and apply such a framework
in designing a tool for phenotyping [46]. In comparison, our recommendations are boom-up,
stemming from an end-to-end exercise of designing, implementing and testing an actual system
with medical professionals. As shown below, all the recommendations are developed from the
lessons mentioned above and can be translated to the next design iteration of Impetus, as well as
extended to other medical AI systems.
Lesson #1 To explain AI’s guidance, suggestions and recommendations, the system should go
beyond a one-size-ts-all concept and provide instance-specic details that allow a medical user to
see evidence that leads to a recommendation.
Recommendation #1: an overview + instance-based explanation of AI’s suggestions.
Currently, Impetus only provides an explanation of the suggested regions at the overview level:
a textual description of the outlier detection method as part of the tutorial and visualization (i.e.,
aention map) that shows the degree of ‘outlying’ across the WSI. As an addition, we can further
incorporate instance-based explanation, i.e., with information specic to a particular patient and a
particular region on the patient’s slide. e idea is to allow pathologists to question why a specic
region is recommended by clicking on the corresponding part of the slide, which prompts the
system to show a comparison between the recommended region and a number of samples from
non-recommended parts of the slide for the physician to contrast features in these regions extracted
by AI. One important consideration is that such an additional explanation should be made available
on-demand rather than shown by default, which could defeat the recommendation boxes’ purpose
to accelerate the pathologists’ examination process.
Lesson #2 Medical diagnosis is seldom a one-shot task, thus AI’s recommendations need to
continuously direct a medical user to lter and prioritize a large task space, taking into account
new information extracted from a user’s up-to-date input.
Recommendation #2: make AI-generated suggestions always available (and constantly
evolving) throughout the process of a (manual) examination. For example, in Impetus, a
straightforward design idea is to show recommendation boxes one aer another. We believe this is
especially helpful when the pathologist might be drawn to a local, zoomed-in region and neglect
looking at the rest of the WSI. e always available recommendation boxes can serve as global
anchors that inform pathologists of what might need to be examined elsewhere beyond the current
view.
Lesson #3 Medical tasks are oen time-critical, thus the benets of AI’s guidance, sugges-
tions and recommendations need to be weighed by the amount of extra eorts incurred and the
actionability of the provided information.
Recommendation #3: weigh the amount of extra eorts by co-designing a systemwith
target medical users, as dierent physicians have dierent notion of time urgency. Emer-
gency room doctors oen deal with urgent cases by making decisions in a maer of seconds, and
internists oen perform examinations in 15-20 minutes per patient, oncologists or implant spe-
cialists might decide on a case via multiple meetings that span days. ere is a sense of timeliness
in all these scenarios, but the amount of time that can be budgeted diers from case to case. To
address such dierences, we further recommend modeling each interactive task in a medical AI
system (i.e., how long it might take for the user to perform each task) and provide a mechanism
that allows physicians to ‘lter out’ interactive components that might take too much time (e.g., the
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aention map in Impetus). Importantly, dierent levels of urgency should be modiable (perhaps
as a one-time setup) by physicians in dierent specialties.
Lesson #4 To guide the examination process with prioritization, AI should help a medical user
narrow in small regions of a large task space, as well as helping them lter out information within
specic regions.
Recommendation #4: use visualization to lter out information, i.e., leverage AI’s re-
sults to reduce information load for the physicians. An example would be a spotlight eect
that darkens parts of a WSI where AI detects lile or no tumor cells. Based on our observation that
pathologists used AI’s results to conrm their examination on the original H&E WSI, such an overt
visualization can help them lter out subsets of the WSI patches. Meanwhile, pathologists can also
reveal a darkened region if they want to examine further AI’s ndings (e.g., when they disagree
with AI, believing a darkened spot has signs of tumor).
Lesson #5 It is possible for medical users to provide labels during their workow with acceptable
extra eort. However, the system should provide explicit feedback on how the model improves as a
result, as a way to motivate and guide medical users’ future inputs.
Recommendation #5: when adapting the model on-the-y, show a visualization that
indicates the model’s performance changes as the physician labels more data. ere could
be various designs of such information, from showing low-level technical details (e.g., the model’s
specicity vs. sensitivity), high-level visualization (e.g., charts that plot accuracy over WSIs read)
and even actionable items (e.g., ‘nudging’ the user to label certain classes of data to balance the
training set). ere are two main factors to consider when evaluating a given design: (i) as we
observed in our study, whether the design could inform the physician of the model’s performance
improvement or degradation as they label more data, which can be measured quantitatively as
the amount of performance gain divided by the amount of labeling work done; (ii) as we noted in
Lesson #2, whether consuming the extra information incurs too much eort and slows down the
agile labeling process and whether there is actionability given the extra information about model
performance changes.
Lesson #6 Tasks treated equally by an AI might carry dierent weights to a medical user. us
for medically high-staked tasks, AI should provide information to validate its condence level.
Recommendation #6: provide additional justication for a negative diagnosis of a high-
staked disease. For example, when Impetus concludes a case as negative, the system can still
display the top ve regions wherein AI nds the most likely signs of tumor (albeit below a threshold
of positivity). In this way, even if the result turned out to be a false negative, the physicians would
be guided to examine regions where the actual tumor cells are likely to appear. Beyond such
intrinsic details, it is also possible to retrieve extrinsic information, e.g., prevalence of the disease
given the patient’s population, or similar histological images for comparison. As suggested in [47],
such extrinsic justication can complement the explanation of a model’s intrinsic process, thus
allowing physicians to understand AI’s decision more comprehensively.
8 DISCUSSION AND CONCLUSION
is paper explores how AI’s capabilities with limitations can still benet a traditional manual
diagnosis process on histological data. We investigate this question through the design and study
of Impetus, a tool where an AI takes multi-leveled initiatives to provide various forms of assistance
to a pathologist performing tumor detection in whole-slide histological images. We conducted
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work sessions with eight medical professionals using Impetus and summarize our ndings and
lessons learned, based on which we provide design recommendations with concrete examples to
inform future work on human-centered medical AI systems.
Below, we discuss several limitations encountered during the development of our system.
Detecting small lesion tissues in aWSI. We found it hard for the system to detect small lesion
tissues in a WSI during the work session. However, from our interviews with medical professionals,
it is more valuable to nd those areas with AI, whereas large, macro tissues can be located quickly
without assistance. Here we summarize the reasons why the machine learning algorithm fails to
localize small lesion tissues. First, the system takes patches as input to extract the features and
classies them with trained MIL-RF. However, this approach can be problematic when detecting
small-area lesion tissues, since the classication performance highly depends on color, and small
metastasis do not change the color of patches signicantly. Further, the machine learning model
treats tissues in a WSI as separate patches without considering structural correlations among the
tissues. Specically, lymph node invasion starts from the perimeters of the node. us small lesion
tissues are more likely to appear in those peripheral regions.
Integration into pathologists’ workow. Data encountered in a pathologist’s day-to-day
workow are imbalanced by nature: metastasis areas oen occupy small fractions of the entire WSI.
As a result, there would be more negative annotations than positive ones. Furthermore, with the
coarse labeling enabled by our MIL algorithm, only a subset of the patches in a positive annotation
are truly positive patches. is imbalance in training data skews the model’s predictions.
On the other hand, to use an AI system for diagnosis, the AI’s performance must be validated.
However, a trained-on-the-y AI can not be practically validated, i.e., it is not feasible to fully
validate the model’s performance aer every iteration of labeling and training, even though the
number of new training data is small. Such a dynamic system is hard to control to maintain a
certain level of performance regardless of run-time user interaction.
Combining prior knowledge. In the real diagnosis environment of a pathologist, extra patient
information is necessary for diagnosing a glass slide, which oen includes the patient’s medical
history and type of cancer as determined from previous examinations. From our interviews with
pathologists, we learn that such information is crucial for diagnosis speed and accuracy, as it
informs the pathologist on what to look for and where to nd them. To beer match the AI with a
pathologist’s mental model and provide beer guidance and explanations, we should incorporate
patient information into the diagnosis model. For example, the AI might use a dierent CNN to
look for a specic type of tumor tissues given a particular cancer type.
Explicit vs. implicit feedback. So far, Impetus primarily relies on explicit feedback from
physicians via agile labeling. Future work should leverage other information as implicit feedback,
e.g., what kinds of WSI areas a pathologist looks at rst, or spends the most time examining, where
and how much they zoom in. Inferring useful information for adapting the model presents new
technical challenges for the machine learning community; for HCI and CSCW researchers, the
challenge is making such inference transparent by informing pathologists how AI is learning from
some of their implicit behavior.
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A IMPLEMENTATION DETAILS OF IMPETUS SOFTWARE
In this section, we introduce the implementation of Impetus. Overall, the soware was wrien in
Python and the detailed implementation of Impetus’ capabilities are shown as follows.
Attentionmap& recommendation boxesWhen the system is rst loaded, Otsu method [? ] is
rst utilized to separate foreground tissues and background. en a pre-trained InceptionResNetv2
model [22] with PatchCamelyon dataset6 extracts patch features in WSIs. e size of each patch is
96 × 96 × 3, and the extracted features have a dimension of 1536. In the rst iteration, the system
performs isolation forest [30] outlier detection based on extracted features, and the detected outliers
are highlighted in the aention map. In the following iterations, the aention map is a combination
of outliers (from the initial detection) and high uncertainty patches (from specic models in each
iteration). Uncertainty is calculated as Uncertainty = 1 − |0.5 − Probability | × 2. e aention
map is calculated as the so-OR of outliers and uncertainty: Attention = Uncertainty  Outlier .
In order to obtain the recommendation boxes, the system uses a DBSCAN clustering algorithm [15]
on the aention map to nd clusters. In each iteration, the recommendation boxes are selected as
the two clusters which occupies the largest areas on the WSI.
Agile labeling Impetus uses an agile labelling technique that does not specically require users
to provide the exact contour of tumor tissues in a WSI, as strongly-supervised learning does.
Alternatively, a user can mark a positive box over an area which contains at least one tumor patches,
or a negative box on all negative regions. We implemented a weakly-supervised multiple instance
learning (MIL) to enable a traditional random forest algorithm learn over such agile labels. As
shown in Algorithm 1, Xi is a feature set in within a box and only has one box-level label Yi . For a
negative box, all the instances in the box can be included in neдative set . In order to distinguish
the real ‘positive’ patch in a positive box, we rst use manifold learning – T-SNE [31] – to represent
6hps://patchcamelyon.grand-challenge.org/
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Algorithm 1 Impetus MIL Training
initialize positive set = [ ], neдative set = [ ]
while Performance not satised do
Annotate X1,X2, . . . ,XN boxes with Y1,Y2, . . . ,YN labels
for Xi do
if Yi == −1 then
neдative set .append(Xi )
else
Embed Xi to X i with T-SNE









Assign each instance in X (1)i with +1 labels, and X
(2)
i with −1 labels
Train a random forest classier with X (1)i and X
(2)
i
Predict negative box Xneд
Adjust the labels of X (1)i and X
(2)
i
Append positive set with positive instances
end if
end for
Train a random forest classier with positive set and neдative set
end while
the 1536 dimension feature Xi with two-dimension embedding X i . Here, it is assumed that the
T-SNE would embed the positive box instances into one positive and one negative cluster, thus




i . By using the split, the original
1536-dimention Xi can be partitioned into X (1)i and X
(2)
i . Aer clustering, the algorithm compares
the two clusters with negative samples from negative box Xneд to pick the real positive cluster.
To achieve this goal, it rst assigns each instance in X (1)i with +1 labels, and that in X
(2)
i with −1
labels, then trains a random forest classier with X (1)i and X
(2)
i . e trained classier is used to
predict negative box instances Xneд previously provided by the user. Finally, the cluster which
has the opposite prediction to the negative box is the positive cluster. Aer the positive cluster
is recognized, all the instances in the positive cluster are included in the positive set , and the
instances in the rest cluster are aborted. Finally, a random forest classier (MIL-RF) is trained with
the obtained positive set and neдative set , and the user can iteratively provide more annotations
until the trained classier reaches a satisfactory level of performance.
Condence calculation Impetus has a rule-based condence-level classier to classify slides
into three categories, namely high-condence, mid-condence and low-condence. As shown in
Algorithm 2, the system rst obtains the predictions of all the patches in the WSI. A patch has
two characteristics: is positive and is uncertain. A patch is positive if the MIL-RF classier output
¿ 0.5, and is uncertain if MIL-RF classier output ∈ [0.25, 0.75]. We empirically summarize the
condence-level decision rules as follows:
• if there are more than 200 positive patches AND the number of positive patches is greater
than twice the number of uncertain patches, then the slide is predicted as high-condence;
• if there are no outlier clusters, then the slide is predicted as low-condence;
• if the number of uncertain patches is greater than 300, then the slide is predicted as
low-condence;
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Algorithm 2 Condence-level Classier
get WSI prediction and uncertainty
if —positive— ¿ 200 && —positive— ¿ 2 × —uncertainty— then
Predict high-condence
else if —Outlier Cluster— == 0 then
Predict low-condence
else if —uncertainty— ¿ 300 then
Predict low-condence





• if the number of positive patches is greater than 200, then the slide is predicted as high-
condence;
• for all other cases, the slide is predicted as mid-condence.
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